SwiftDuct News
2 articles
growth-positive
SwiftDuct Presents Positive Clinical Study Results of SwiftGlide For ERCP Procedures at ESGE Days 2024
SwiftDucts first clinical study at Galilee Medical Center shows that its electrochemical navigation method can improve ERCP procedures and outcomes. The study was presented at the 2024 annual meeting of the European Society of Gastrointestinal Endoscopy. The study showed that SwiftGlide, SwiftDucts electrochemical navigation system for ERCP procedures, was successful in differentiating between bile and pancreatic/mixed juices. This differentiation provides the first ever opportunity for the most accurate ERCP, without, or with a minimal need for fluoroscopy.
Customers
growth-positive
MEDX Xelerator invests in 3 new Israeli MedTech startups
Israeli MedTech incubator MEDX Xelerator has invested $2.5 million in three early-stage startups: Swift Duct, Synchrony Medical, and Dimoveo Medical. Swift Duct develops a navigational tool for medical procedures, Synchrony Medical develops a smart vest for COPD patients, and Dimoveo Medical develops disinfection technologies for implants. The investments aim to improve medical treatments and upgrade the healthcare system.
Investment
